Invention Grant
- Patent Title: Substituted pyridines, and use thereof as GSK3 inhibitors
- Patent Title (中): 取代的吡啶，并将其用作GSK3抑制剂
-
Application No.: US13056676Application Date: 2009-07-21
-
Publication No.: US08664246B2Publication Date: 2014-03-04
- Inventor: Stephan Siegel , Andreas Wilmen , Niels Svenstrup , Mark Jean Gnoth , Adrian Tersteegen , Ulrich Rester
- Applicant: Stephan Siegel , Andreas Wilmen , Niels Svenstrup , Mark Jean Gnoth , Adrian Tersteegen , Ulrich Rester
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: DE102008035552 20080730
- International Application: PCT/EP2009/005266 WO 20090721
- International Announcement: WO2010/012398 WO 20100204
- Main IPC: A61K31/4545
- IPC: A61K31/4545 ; C07D401/12
Abstract:
The invention relates to substituted pyridines and to processes for preparation thereof, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of haematological disorders, preferably of leukopenia and neutropenia.
Public/Granted literature
- US20110190316A1 Substituted pyridines, and use thereof as Gsk3 inhibitors Public/Granted day:2011-08-04
Information query
IPC分类:
